Pancreatic Cancer Research

ResearcherKyushu UniversityActive in the last 2 years

Akira Imaizumi

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 7 November 2026

Known by name at one institution; no external author ID yet. Sources: OpenAlex.

Their work

Papers
8 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
15
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: 3 papers · 2017: 1 paper · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper · 2024: 1 paper

Papers 8

  1. A Novel Oncolytic Viral Therapy Using Coxsackievirus B3 (CVB3) for Human Pancreatic Cancer Including Cancer-associated Fibroblasts. First author DOI 10.21873/anticanres.17348↗
  2. C4orf47 contributes to the dormancy of pancreatic cancer under hypoxic conditions. Co-author DOI 10.7150/jca.78993↗
  3. Patched 1-interacting Peptide Represses Fibrosis in Pancreatic Cancer to Augment the Effectiveness of Immunotherapy. Co-author DOI 10.1097/cji.0000000000000305↗
  4. Liprin-α4 as a Possible New Therapeutic Target for Pancreatic Cancer. Co-author DOI 10.21873/anticanres.12122↗
  5. Hypoxia but not normoxia promotes Smoothened transcription through upregulation of RBPJ and Mastermind-like 3 in pancreatic cancer. Co-author DOI 10.1016/j.canlet.2015.11.012↗
  6. Hypoxic Conditions Promote Gemcitabine Sensitivity in a Pancreatic Cancer Stem Cell Line. Co-author PMID 26851020↗
  7. Protein-bound Polysaccharide-K Inhibits Hedgehog Signaling Through Down-regulation of MAML3 and RBPJ Transcription Under Hypoxia, Suppressing the Malignant Phe… Co-author PMID 27466498↗
  8. Reoxygenation from chronic hypoxia promotes metastatic processes in pancreatic cancer through the Hedgehog signaling. Co-author DOI 10.1111/cas.12348↗

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hideya Onishi · 8 shared papers, 2014–2024 · strength 0.78
  2. Makoto Kawamoto · 6 shared papers, 2016–2023 · strength 0.53
  3. Masafumi Nakamura · 3 shared papers, 2020–2024 · strength 0.45
  4. Akio Yamasaki · 4 shared papers, 2016–2017 · strength 0.28
  5. Yasuhiro Oyama · 3 shared papers, 2016–2020 · strength 0.23
  6. Hisanobu Ogata · 1 shared paper, 2024 · strength 0.20
  7. Kenzaburo Tani · 1 shared paper, 2024 · strength 0.20
  8. Mitsuo Katano · 3 shared papers, 2014–2016 · strength 0.19
  9. Takashi Morisaki · 2 shared papers, 2016–2020 · strength 0.16
  10. Yoshinao Oda · 1 shared paper, 2023 · strength 0.15
  11. Shinjiro Nagao · 1 shared paper, 2023 · strength 0.15
  12. Kenoki Ohuchida · 1 shared paper, 2020 · strength 0.10
  13. Kenichiro Hasumi · 1 shared paper, 2016 · strength 0.07
  14. Yoshihiro Morifuji · 1 shared paper, 2014 · strength 0.05
  15. Masao Tanaka · 1 shared paper, 2014 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.